B.Pharm

i3 is a full-service Clinical Research Organization (CRO) focused on five therapeutic areas: Oncology; Cardiology; The Central Nervous System; Respiratory and Infectious Diseases; and Endocrinology and Metabolic diseases. Therapeutic specialization drives all aspects of business in this global CRO - from project staffing and talent management to quality initiatives.

About Authors:
Jyotirmoy Das Choudhury, Dr. Biplab De,
Department of Pharmaceutical Chemistry.
Regional Institute of Pharmaceutical Science and Technology. Abhoynagar, Agartala,
Tripura(W)

INTRODUCTION
Nature always stands as a golden mark to exemplify the outstanding phenomenon of symbiosis. The biotic & abiotic elements of nature are all interdependent. The plants are indispensable to man for his life. The knowledge of drug has accumulated over  thousands of years as a result of man’s inquisitive nature so that today we posses many effective means of ensuring health care.
In the part, almost all the medicines used were from the plants, the plant being men’s only chemist for ages. The history of medical plants dates back to RIG VEDA, perhaps the oldest repository of human knowledge, which was written in about 4500-1600 B.C. then there is the Ayurveda which given us detail accounts of many herbal drugs. Most of the medicinally active substance are identified in the 19^th & 20^th centuries was used in crude form. But now in modern days we use to take drug in the form of dosage form.

At i3 Global, We believe in science for the sake of people—in the end, it’s about better patient care.
Because we are a service organization through and through, we’ll build a relationship to suit your specialized needs. Tell us what you need and where in the world you want us to be, and we will deliver.

J. B. Chemicals & Pharmaceuticals Ltd. (JBCPL), known to many as Unique Pharmaceutical Laboratories is one of India's leading global pharmaceutical companies. The company manufactures and markets a wide range of pharmaceutical formulations.

Post:  ADL - Officer

Pharmacopoeia Commission for Indian Medicine (PCIM) is an autonomous body established in 2010 with the approval of Govt. of India with an objective to develop Pharmacopoeial standards for Ayurveda, Siddha and Unani drugs and to publish Ayurvedic, Unani and Siddha Pharmacopoeia of India for the promotion of Quality and Safety of ASU Drugs for the furtherance of provisions of Chapter-IV of Drugs and Cosmetics Act-1940 and Rules-1945 of Ayurvedic, Unani and Siddha drugs.

About Authors:
V. Ravi Chandra
Research Associate
Parexel
B.Pharmacy from Priyadarshini College of pharmacy,
Osmania University,
Hyderabad, AP, INDIA

Abstract:
Huntington's disease is an intricate illness. It is a neurodegenerative, insidious disorder-which means it is harmful and fatal but gradually. The onset of the disease is very late to diagnose the disease. Huntington's disease (HD) also called as ‘Huntington’s Chorea’. Chorea means dance in Greek, which is aftereffect of genetically programmed degeneration of brain cells, called neurons, in certain areas of the brain. This degeneration causes uncontrolled movements, loss of intellectual faculties, and emotional disturbance. By choreic movement physically we can diagnose HD. HD is also a familial disease, passed from parent to child through a mutation in the normal gene. Attempts to study early disease are not unique in neurology (e.g., mild cognitive impairment and vascular cognitive impairment), but studying otherwise healthy-appearing individuals who have nearly 99% certainty of manifesting the symptoms of brain disease does provide distinct but valuable information about the true natural history of the disease. A genetic test, coupled with a complete medical history and neurological and laboratory tests, helps physicians diagnose HD. Presymptomic testing is available for individuals who are at risk for carrying the HD gene. HD occurs in about one out of every 10,000 Caucasian individuals. In India, the cases are unknown because of failure of doctors to diagnose HD as they never seen HD in their practice. Approximately 2.5 times more individuals are at risk for the disorder because of the midlife peak in age at onset.

The University Institute of Pharmaceutical Sciences of the Panjab University is a premier institution of Pharmaceutical Education and Research in the country.

NEEDS PHARMA, We would like to introduce ourselves a WHO - GMP certified manufacturing unit from INDIA willing to turn the milestone in Pharmaceutical era.
We manufacture Tablets, Capsule, Syrups, Suspensions and other formulations and are exporting to various countries across the Globe.